KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Opko Health (OPK) EBT (2016 - 2026)

Opko Health filings provide 17 years of EBT readings, the most recent being -$61.0 million for Q1 2026.

  • On a quarterly basis, EBT rose 16.92% to -$61.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$228.9 million, a 92.84% decrease, with the full-year FY2025 number at -$241.4 million, down 2229.32% from a year prior.
  • EBT hit -$61.0 million in Q1 2026 for Opko Health, down from -$46.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $48.4 million in Q3 2024 to a low of -$162.5 million in Q2 2025.
  • Median EBT over the past 5 years was -$72.9 million (2023), compared with a mean of -$57.7 million.
  • Biggest five-year swings in EBT: soared 161.78% in 2024 and later crashed 1435.53% in 2025.
  • Opko Health's EBT stood at -$102.2 million in 2022, then increased by 29.05% to -$72.5 million in 2023, then surged by 166.79% to $48.4 million in 2024, then crashed by 196.86% to -$46.9 million in 2025, then fell by 29.97% to -$61.0 million in 2026.
  • The last three reported values for EBT were -$61.0 million (Q1 2026), -$46.9 million (Q4 2025), and $41.4 million (Q3 2025) per Business Quant data.